HK-BAY-143b

Expert Meeting 2023: Navigating the latest treatment landscape of mHSPC

Post-meeting survey

*Mandatory

1. Please select your institution. *

a. Hospital Authority
b. Private
c. Others

2. Please rate the followings with a scale 1 (strongly disagree) to 5 (strongly agree): *

	1 - Strongly Disagree	2	3	4	5 - Strongly Agree
The pre-reading, survey, and delivery of the meeting were useful and well organised	1 - Strongly DisagreeThe pre-reading, survey, and delivery of the meeting were useful and well organised 1 - Strongly Disagree	2The pre-reading, survey, and delivery of the meeting were useful and well organised 2	3The pre-reading, survey, and delivery of the meeting were useful and well organised 3	4The pre-reading, survey, and delivery of the meeting were useful and well organised 4	5 - Strongly AgreeThe pre-reading, survey, and delivery of the meeting were useful and well organised 5 - Strongly Agree
The presentations are informative and met the objectives	1 - Strongly DisagreeThe presentations are informative and met the objectives 1 - Strongly Disagree	2The presentations are informative and met the objectives 2	3The presentations are informative and met the objectives 3	4The presentations are informative and met the objectives 4	5 - Strongly AgreeThe presentations are informative and met the objectives 5 - Strongly Agree
The case study and discussion are insightful	1 - Strongly DisagreeThe case study and discussion are insightful 1 - Strongly Disagree	2The case study and discussion are insightful 2	3The case study and discussion are insightful 3	4The case study and discussion are insightful 4	5 - Strongly AgreeThe case study and discussion are insightful 5 - Strongly Agree
Overall, I am satisfied with this meeting	1 - Strongly DisagreeOverall, I am satisfied with this meeting 1 - Strongly Disagree	2Overall, I am satisfied with this meeting 2	3Overall, I am satisfied with this meeting 3	4Overall, I am satisfied with this meeting 4	5 - Strongly AgreeOverall, I am satisfied with this meeting 5 - Strongly Agree

3. In your clinical practice, what would be the most common regimen used to treat patients with mHSPC? *

4. Disregarding the concern of cost, what would be your preferred treatment regimen for de novo high-volume mHSPC patients? *

5. Similarly, what would be your first treatment choice for patients with low-volume but high risk mHSPC? *